Instructions for jHASE authors
 

General information for jHASE authors

Prospective authors are advised to also read About this journal, which includes other relevant information.

Submission process

To facilitate rapid publication and to minimize administrative costs, jHASE  currently accepts submissions through the online journal system (OJS) with attachments of article text and figures/illustrations formatted according to additional instructions for authors provided in this document for each article type. 

Publication and peer review processes

Unless they are outside the scope for the journal or are of an unacceptably low standard of presentation, submitted articles will be sent to peer reviewers. They will generally be reviewed by 2-3 subject experts with the aim of reaching a first decision as soon as possible. Section Editors are assisted by peer-review fellows with consolidation of reviewer reports or with any additional literature reference work that may be needed. Statistical reviewers are also used where required, as determined by the Section Editor. Reviewers are asked to declare any competing interests and have to agree to open peer review, which works on two levels: the authors receive the signed report and, if the manuscript is published, the same report is available to the readers. The pre-publication history (initial submission, reviews and revisions - see, for example, pre-publication history) may be posted on the web with the published article or made available on request.

To expedite publication and reduce costs of developing a large pool of relevant peer reviewers, jHASE requires that all authors provide the contact details (including e-mail addresses) of at least four to five (4-5) potential peer reviewers for their manuscript. These should be knowledgeable on the topic of the manuscript submitted as they need to be able to provide an objective assessment of the manuscript. Any suggested peer reviewers should not have published with any of the authors of the manuscript within the past five years and should not be members of the same research institution. Members of the Advisory Editorial Board can be nominated, except Editor(s)-in-Chief, Associate/Senior Editors, Section Editors, and Managing Editors of the journal. Suggested reviewers will be considered alongside potential reviewers identified by their publication record or recommended by Editorial Board members. To leave this page and read more information on requirements for qualifications and experience of peer reviewers for jHASE publications, click here.

Reviewers are asked whether the manuscript is scientifically sound and coherent, how interesting it is and whether the quality of the writing is acceptable. Where possible, the final decision is made on the basis that the peer reviewers are in accordance with one another, or that at least there is no strong dissenting view. In cases where there is strong disagreement either among peer reviewers or between the authors and peer reviewers, advice is sought from a panel of senior members of the journal's Editorial Board. The journal allows a maximum of two revisions of any manuscripts. The ultimate responsibility for any peer review decision lies with the Editors-in-Chief.

Reviewers are also asked to indicate which articles they consider to be especially interesting or significant. These articles may be given greater prominence and greater external publicity.

Once an article is accepted, it is published in jHASE immediately as a provisional PDF file. The paper will be subsequently  published in both fully browseable web form, and as a formatted PDF; the article will then be available through jHASE (published by IEPH, Inc.) and indexed and archived in the World Health Organization(WHO)-sponsored African Index Medicus(AIM) and searchable through Google Scholar Search for AIM . jHASE expects to have it's AIM-indexed publications to be retroactively cross-indexed in Pubmed Medline after about 12 months of publication track-record, which is what's typically required to qualify for Medline indexing. Following publication in jHASE, the full text of each article is immediately and permanently archived in IEPH's literature repository (pending archiving in PubMed Central, the US National Library of Medicine's full-text repository of life science literature and indexing in MEDLINE).

At this time, authors may track the progress of their paper at any time by logging in to the jHASE online journal system (OJS).

Article-processing charges

To ensure that all worthy and accepted manuscripts can be published in jHASE regardless of the authors' ability to pay, jHASE routinely waives article-processing charges for qualifying authors . For further details, please see more information about article-processing charges.

Supplemental editorial policies

Any manuscript submitted to the journal must not already have been published in another journal or be under consideration by any other journal, although it may have been deposited on a preprint server. Manuscripts that are derived from papers presented at conferences can be submitted unless they have been published as part of the conference proceedings in a peer reviewed journal. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party. Authors who publish in jHASE retain copyright to their work (more information on license). Correspondence concerning articles published in jHASE is encouraged.

Submission of a manuscript to jHASE implies that all authors have read and agreed to its content, and that any experimental research on humans or animals that is reported in the manuscript has been performed with the approval of an appropriate ethics committee, and is in compliance with the Helsinki Declaration. A statement to this effect must be included in the Methods section of the manuscript. Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses in the Methods section.

We ask authors of jHASE papers to complete a declaration of competing interests, which should be provided as a separate section of the manuscript, to follow the Acknowledgements. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'. Much has been written about competing interests (or conflict of interest, as other journals call it) within scientific research, but the following articles provide some background:

For all articles that include information or clinical photographs relating to individual patients, written and signed consent from each patient to publish must also be mailed or faxed to the editorial staff. The manuscript should also include a statement to this effect in the Acknowledgements section, as follows: "Written consent was obtained from the patient or their relative for publication of study".

jHASE and its publisher, IEPH, Inc., support initiatives to improve the performance and reporting of clinical trials, part of which includes prospective registering and numbering of trials. While there are initiatives to ensure that all clinical trials are registered (most notably the recent statement from the International Committee of Medical Journal Editors - see http://www.icmje.org/clin_trial.pdf), we are focussing on randomised controlled trials, for now. Authors of protocols or reports of randomised controlled trials must register their trial prior to submission in a publicly accessible registry. The trial registration number must be included in the title of the manuscript. One such number is the International Standard Randomised Controlled Trial Number (ISRCTN), which can be obtained by completing an online application form http://www.controlled-trials.com/isrctn/submission/.

jHASE and its publisher, IEPH, Inc., also support initiatives aimed at improving the reporting of biomedical research. Checklists have been developed for randomized controlled trials (CONSORT), systematic reviews (QUORUM), and meta-analyses of observational studies (MOOSE). Authors are requested to make use of these when drafting their manuscript and peer reviewers will also be asked to refer to these checklists when evaluating these studies. For authors of systematic reviews, a supplementary file, linked from the Methods section, should reproduce all details concerning the search strategy. For an example of how a search strategy should be presented, see the Cochrane Reviewers' Handbook.

Authors from pharmaceutical companies, or other commercial organizations that sponsor clinical trials, should adhere to the Good Publication Practice guidelines for pharmaceutical companies, which are designed to ensure that publications are produced in a responsible and ethical manner. The guidelines also apply to any companies or individuals that work on industry-sponsored publications, such as freelance writers, contract research organizations and communications companies.

Submission of a manuscript to jHASE implies that readily reproducible materials described in the manuscript will be freely available to any scientist wishing to use them for non-commercial purposes. Nucleic acid sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the published article. In computational studies where the sequence information is unacceptable for inclusion in databases because of lack of experimental validation, the sequences must be published as an additional file with the article. Where appropriate, authors should adhere to the standards proposed by the Microarray Gene Expression Data Society (http://www.mged.org) and must deposit microarray data in one of the public repositories, such as ArrayExpress (http://www.ebi.ac.uk/arrayexpress), Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/projects/geo/) or the Center for Information Biology Gene Expression Database (CIBEX; http://cibex.nig.ac.jp).

Any 'in press' articles cited within the references and necessary for the reviewers' assessment of the manuscript should be made available if requested by the editorial office.

The publisher of jHASE, IEPH, Inc., subscribes to the guidelines and code of conduct of the Committee on Publication Ethics (COPE); for more information, visit www.publicationethics.org.uk

return to top

Preparing main manuscript text for jHASE article submissions

File formats

The following word processor file formats are acceptable for the main manuscript document:

  • Microsoft Word (version 2000 - 2003)
  • Rich text format (RTF)

Users of other word processing packages should save or convert their files to RTF before uploading. Many free tools are available which ease this process.

PLEASE NOTE: Figures and tables must be also be submitted as separate files (a DOC/RTF/PPT and a PDF of each figure or table), in addition to those inserted within the manuscript at the appropriate points.

Journal Focus Areas and General Article Types Descriptions:
When submitting your manuscript, you will be asked to assign one of the following types to your article:

More Details of Article Types, Manuscript Sections (and examples)

Research article

Case report

Database

Debate or Review Article

Software (incl.Statistical Analysis Programs)

Study protocol

Technical advance

Please read the descriptions of each of the article types, choose which is appropriate for your article and structure it accordingly. If in doubt, your manuscript should be classified as a Research article, the structure for which is described below.

Manuscript sections/Research article format

Manuscripts for Research articles submitted to jHASE should be divided into the following sections:

You can download a template (Mac and Windows compatible; Microsoft Word 98/2000) for your article. For instructions on use, see below.

The Accession Numbers of any nucleic acid sequences, protein sequences or atomic coordinates cited in the manuscript should be provided, in square brackets and include the corresponding database name; for example, [EMBL:AB026295, EMBL:AC137000, DDBJ:AE000812, GenBank:U49845, PDB:1BFM, Swiss-Prot:Q96KQ7, PIR:S66116].

The databases for which we can provide direct links are: EMBL Nucleotide Sequence Database (EMBL), DNA Data Bank of Japan (DDBJ ), GenBank at the NCBI (GenBank), Protein Data Bank (PDB), Protein Information Resource (PIR) and the Swiss-Prot Protein Database (Swiss-Prot).

  • Title page

    This should list the title of the article. The title should include the study design, for example:

A versus B in the treatment of C: a randomized controlled trial

X is a risk factor for Y: a case control study

Randomized controlled trials should include a trial registration number in square brackets at the end of the title. One such number is the International Standard Randomised Controlled Trial Number (ISRCTN). For an example, see the BAFTA trial.

The full names, institutional addresses, and e-mail addresses for all authors must be included on the title page. The corresponding author should also be indicated.

  • Abstract

    The abstract of the manuscript should not exceed 350 words and must be structured into four separate sections: Objectives and Background, the purpose of the study and context; Methods, design, how the study was performed and statistical analyses used; Results, the main findings; Conclusions, brief summary and potential implications. Please minimize the use of abbreviations and do not cite references in the abstract.

  • Objectives, Background and Rationale

    The objectives/purpose/aims of the study must be described clearly and concisely. The background section should be written from the standpoint of researchers without specialist knowledge in that area and must clearly state - and, if not implicitly obvious, the rationale for the research must be explicitly stated. Reports of research should, where appropriate, include a summary of the hypotheses, a review of the literature to indicate the background of what is known about the subject to further illuminate the rationale for why this study was necessary and objectives/what it aimed to contribute to the field. The section should, where appropriate, end with a very brief statement of what is being reported in the article.

  • Methods

    This should include the design of the study, the setting, the type of participants/study population or materials involved, a clear description of all study procedures, interventions and comparisons, and the type of statistical analyses methods used, including a power calculation if appropriate.

  • Results and Discussion

    The Results and Discussion may be combined into a single section or presented separately. Results of statistical analysis should include, where appropriate, relative and absolute risks or risk reductions, and confidence intervals. The results and discussion sections may also be broken into subsections with short, informative headings.

  • Conclusions

    This should state clearly the main conclusions of the research and give a clear explanation of their importance and relevance. Summary illustrations may be included.

  • List of abbreviations

    If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided, which should precede the competing interests and authors' contributions.

  • Competing interests

    A competing interest exists when your interpretation of data or presentation of information may be influenced by your personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment were they to become public after the publication of the manuscript.

Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'.

When completing your declaration, please consider the following questions:

Financial competing interests

  • In the past five years have you received reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? Is such an organization financing this manuscript (including the article-processing charge)? If so, please specify.
  • Do you hold any stocks or shares in an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? If so, please specify.
  • Do you hold or are you currently applying for any patents relating to the content of the manuscript? Have you received reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript? If so, please specify.
  • Do you have any other financial competing interests? If so, please specify.

Non-financial competing interests

Are there any non-financial competing interests (political, personal, religious, academic, intellectual, commercial or any other) to declare in relation to this manuscript? If so, please specify.

If you are unsure as to whether you, or one your co-authors, has a competing interest please discuss it with the editorial office.

  • Authors' contributions

    In order to give appropriate credit to each author of a paper, the individual contributions of authors to the manuscript should be specified in this section.

An "author" is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should have contributed to substantial aspects of each of the  following: 1) have made substantial contributions to conception and design of key aspects; 2) acquisition of data, or planning/implementing analysis and interpretation of data; 3) have been involved in drafting the article or revising it critically for important/substantive intellectual content (see section below on acknowledgements for appropriate recognition of those whose contribution is mainly to organization, presentation, look and feel); and 4) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. PLEASE NOTE: Acquisition of funding, collection of data/acquisition of data, or general supervision of the research group , alone, does not justify authorship (for contributions which are mainly supervisory, please see section below on acknowledgements for appropriate recognition of those whose contribution is mainly in this regard). jHASE strongly discourages and disqualifies manuscripts violating the above principles of authorship. 

We suggest the following kind of format (please use initials to refer to each author's main contribution) with 2 sections as per example below:
 
Individual authors' main contributions: AB carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. JY carried out the immunoassays. MT participated in the sequence alignment. ES participated in the design of the study and performed the statistical analysis. FG conceived of the study, and participated in its design and coordination and helped to draft the manuscript.

All authors contributed to:
1) conception and design of key aspects; 2) acquisition of data, or planning/implementing analysis and interpretation of data; 3) drafting the article or revising it critically for important/substantive intellectual content; and 4) read and approved the final manuscript.

All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support.

  • Acknowledgements

    These should be kept to a minimum. Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements.

  • References

    All references must be numbered consecutively, in square brackets, in the order in which they are cited in the text, followed by any in tables or legends. Each reference must have an individual reference number. Please avoid excessive referencing. If automatic numbering systems are used, the reference numbers must be finalized and the bibliography must be fully formatted before submission.

Only articles and abstracts that have been published or are in press, or are available through public e-print/preprint servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in the reference list, but may be included in the text. Notes/footnotes are not allowed. Obtaining permission to quote personal communications and unpublished data from the cited author(s) is the responsibility of the author. Journal abbreviations follow Index Medicus/MEDLINE. Citations in the reference list should contain all named authors, regardless of how many there are. There should usually be no more than 50 references per article.

We encourage authors to use a recent version of EndNote (version 5 and above, compatible with version 10) or Reference Manager (compatible with version 10) when formatting their reference list, as this allows references to be automatically extracted. Authors submitting articles in EndNote 5 or higher (compatible with version 10) or Reference Manager 10 format will save 10% on the $1000 article processing charge (for authors with applicable article processing charges). In order to obtain this discount, you should submit the manuscript file containing your EndNote (or later versions compatible with version 10) or Reference Manager-formatted bibliography as a .doc file compatible with Word 2003. Your invoice will reflect this discount and you will receive confirmation by email. Subsequent to submission of your article, you will also be able to preview an HTML version of the extracted references, and will receive a URL on the invoice. EndNote (or later versions compatible with version 10) or Reference Manager users should also make sure that any changes made to the reference list are done within their reference management program, rather than by manually editing the formatted bibliography. This is because manually introduced changes will not be picked up in the automatically extracted list.

Further details about EndNote and Reference Manager are available on their respective sites, including information about how to upgrade.

  • Style files that conform to the template for BMC Public Health's style are available for EndNote and Reference Manager. Users of other reference management programs should be able to select other journal styles that output a numeric list styled similarly to the guide below.

  • Examples of the jHASE reference style are shown below. Please take care to follow the reference style precisely; references not in the correct style may be retyped, necessitating tedious proofreading, and will result .

Links

Web links and URLs should be included in the reference list. They should be provided in full, including both the title of the site and the URL, in the following format: The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/cancer_links.html]

jHASE reference style

Article within a journal

1. Koonin EV, Altschul SF, Bork P: BRCA1 protein products: functional motifs. Nat Genet 1996, 13:266-267.

Article within a journal supplement

2. Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I: Analysis and assessment of ab initio three-dimensional prediction, secondary structure, and contacts prediction. Proteins 1999, Suppl 3:149-170.

In press article

3. Kharitonov SA, Barnes PJ: Clinical aspects of exhaled nitric oxide. Eur Respir J, in press.

Published abstract

4. Zvaifler NJ, Burger JA, Marinova-Mutafchieva L, Taylor P, Maini RN: Mesenchymal cells, stromal derived factor-1 and rheumatoid arthritis [abstract]. Arthritis Rheum 1999, 42:s250.

Article within conference proceedings

5. Jones X: Zeolites and synthetic mechanisms. In Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Edited by Smith Y. Stoneham: Butterworth-Heinemann; 1996:16-27.

Book chapter, or article within a book

6. Schnepf E: From prey via endosymbiont to plastids: comparative studies in dinoflagellates. In Origins of Plastids. Volume 2. 2nd edition. Edited by Lewin RA. New York: Chapman and Hall; 1993:53-76.

Whole issue of journal

7. Ponder B, Johnston S, Chodosh L (Eds): Innovative oncology. In Breast Cancer Res 1998, 10:1-72.

Whole conference proceedings

8. Smith Y (Ed): Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Stoneham: Butterworth-Heinemann; 1996.

Complete book

9. Margulis L: Origin of Eukaryotic Cells. New Haven: Yale University Press; 1970.

Monograph or book in a series

10. Hunninghake GW, Gadek JE: The alveolar macrophage. In Cultured Human Cells and Tissues. Edited by Harris TJR. New York: Academic Press; 1995:54-56. [Stoner G (Series Editor): Methods and Perspectives in Cell Biology, vol 1.]

Book with institutional author

11. Advisory Committee on Genetic Modification: Annual Report. London; 1999.

PhD thesis

12. Kohavi R: Wrappers for performance enhancement and oblivious decision graphs. PhD thesis. Stanford University, Computer Science Department; 1995.

Link / URL

13. Mouse Tumor Biology Database [http://tumor.informatics.jax.org/cancer_links.html]

  • How to cite jHASE articles

    Information on how to cite jHASE articles is provided under the section "Citing jHASE articles in journals" on the "About jHASE" web page.
     

  • Microsoft Word template

    Although we can accept manuscripts prepared as Microsoft Word or RTF (or PDF files with pre-approval from jHASE), we have designed a Microsoft Word template that can be used to generate a standard style and format for your article. This template needs to be used if you have not yet started to write your paper or if it is already written,  your manuscript will need to be put into jHASE style at the time of submission (PLEASE NOTE: managing editor pre-approval is required for initial submission of review versions of manuscripts previously written in a different style, and this will only be granted if the manuscript reasonably contains all the key sections and elements of the jHASE style, and only on condition that a final revised manuscript version set to the jHASE style using the template will be submitted for the final round of review, if accepted with revisions).

Download the template (Mac and Windows compatible Word 1998/2000) from our site, and save it to your hard drive. For Windows users, right-click and select "save target as" to save template on your computer or  Double click the template to open it.

  • How to use the jHASE template

    The template consists of a standard set of headings that make up a jHASE Research article manuscript, along with dummy fragments of body text. Follow these steps to create your manuscript in the standard format:

  • Replace the dummy text for Title, Author details, Institutional affiliations, and the other sections of the manuscript with your own text (either by entering the text directly or by cutting and pasting from your own manuscript document).
  • If there are sections which you do not need, delete them (but check the rest of the Instructions for Authors to see which sections are compulsory).
  • If you need an additional copy of a heading (e.g. for additional figure legends) just copy and paste.
  • For the references, you may either manually enter the references using the reference style given, or use bibliographic software to insert them automatically. We provide style files for End Note and Reference Manager.

For extra convenience, you can use the template as one of your standard Word templates. To do this, put a copy of the template file in Word's 'Templates' folder, normally C:\Program Files\Microsoft Office\Templates on a PC. The next time you create a new document in Word using the File menu, the template will appear as one of the available choices for a new document.

Note - From version 6 and later, EndNote includes a full set of structured article templates for BMC Public Health, which are compatible with acceptable for jHASE submissions. Users of EndNote are encouraged to upgrade if necessary and make use of these templates. More information is available here.

return to top

Preparing illustrations and figures

In addition to inserting/embedding illustrations in the text file of the Word template of the submission manuscript at the appropriate locations indicated in the template, illustrations should ALSO be provided and uploaded as separate files using formats described below. This means that each figure should include a single composite illustration, which should be a separate graphics file inserted into the text and also provided as a separate file in formats described below. There is no charge for the use of color figures. Each figure should be closely cropped to minimize the amount of white space surrounding the illustration.

PLEASE NOTE: As described above, if a figure consists of separate parts, it is important that a single composite illustration file be submitted which contains all parts of the figure.

Photographs should be provided with a scale bar if appropriate, as well as high-resolution component files. If photographs of patients' body parts, X-rays or scans are given as part of the manuscript, written and signed consent of the patient should also be scanned and e-mailed or faxed to the editors.

Scaling/resolution

Illustrations should be designed such that all information is legible when scaled to a horizontal width of 600 pixels, since this is the default size for a jHASE illustration on the web. High-quality versions of figures will also be generated and stored by jHASE, however, so image files should be submitted at a resolution of 300 dpi or greater if possible.

Text within figures should use either Arial or Helvetica fonts, although Courier may also be used if a monospaced font is required. Text too should be designed to be legible when the illustration is scaled to a width of 600 pixels.

Formats

The following file formats can be accepted for the separate files of figures/illustrations submitted:

  • Insert figures into Microsoft Word files (version 2000 - 2003; figures must be A4 portrait, and not exceed a single page); figures may be inserted within the Word template of the submission article or in a separate Word document;
  • Insert figures into PowerPoint files, compatible with versions 2000 - 2003) (figures must be a single page);
  • PDF (especially suitable for diagrams);
  • Other formats which may be considered with prior approval by jHASE (depending on quality of figures submitted, poor quality figures may be returned for resubmission in better formats):
    • JPEG (only if saved at High or Maximum quality);
    • TIFF
    • BMP
    • GIF (least preferred)

If the large size of TIFF or BMP figures are pre-approved but are an obstacle to e-mail/online submission, authors may find that conversion to JPEG format before submission results in significantly reduced file size (and e-mail/online upload time), while retaining acceptable quality. JPEG is a 'lossy' format, however. In order to maintain acceptable image quality, it is recommended that JPEG files are saved at High or Maximum quality.

There is not likely to be much gain in reducing file size from use of file compression tools such as Zipit or Stuffit prior to submission. These tools will in any case produce negligible file-size savings for JPEGs and TIFFs, which are already compressed.

Image conversion tools

There are many software packages, many of them freeware or shareware, capable of converting to and from different graphics formats, including PNG.

Good general tools for image conversion include GraphicConverter on the Macintosh, PaintShop Pro, for Windows, and ImageMagick, which is available on Macintosh, Windows and UNIX platforms.

About EPS format: Note that bitmap images (e.g. screenshots) should not be converted to EPS since this will result in a much larger file size than the equivalent JPEG, TIFF, PNG or BMP, with no increase in quality. EPS should only be used for images produced by vector drawing applications such as Adobe Illustrator or CorelDraw. In all instances, vector drawing application images and EPS formats must be converted and submitted in PDF format and not EPS format.

About images originally prepared in an Office application, such as Word or PowerPoint, then the Office files should be submitted in this Office application, rather than converted to JPEG or another format that may be of reduced quality.

Figure legends

For figures included in the DOC or RTF files, figure legends (including titles, and footnotes) should also be included in the main manuscript text, immediately following the references, rather than being a part of the figure file. The following information should be provided, for each figure: Figure number (in sequence, using Arabic numerals - i.e. Figure 1, 2, 3 etc); short title of figure (maximum 15 words); detailed legend, up to 300 words.

Please Note: It is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures or tables that have previously been published elsewhere.

return to top

Preparing tables

As described above under the section on illustrations, in addition to inserting tables in the text file of the Word template of the submission manuscript at the appropriate locations indicated in the template, tables should ALSO be provided and uploaded as separate files as described herein. Each table should be numbered in sequence using Arabic numerals (i.e. Table 1, 2, 3 etc.). Tables should also have a title that summarizes the whole table, maximum 15 words. Detailed legends may then follow, but should be concise.

As is applicable to all tables, smaller tables considered to be integral to the manuscript must also be pasted into the document text file in portrait format in the text file of the Word template of the submission manuscript at the appropriate locations for tables and figures indicated in the template. If the manuscript is accepted, jHASE will also typeset and display such tables in the final published form of the article. Such tables should be formatted using the 'Table object' in a word processing program to ensure that columns of data are kept aligned when the file is sent electronically for review; this will not always be the case if columns are generated by simply using tabs to separate text, and therefore, tabbed tables will not be accepted. Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines. Commas should not be used to indicate numerical values. Color and shading should not be used in tables.

Larger datasets can be uploaded separately as additional files. Additional files will not be displayed in the final, published form of the article, but a link will be provided to the files as supplied by the author.

Tabular datasets provided as additional files can be uploaded as an Excel spreadsheet compatible with Excel 2000 - 2003 (.xls) or comma separated values (.csv). As with all files, please use the standard file extensions.

return to top

Preparing additional files

Although jHASE does not restrict the length and quantity of data in a paper, there may still be occasions where an author wishes to provide data sets, tables, movie files, or other information as additional information. These files can be uploaded using the 'Additional Material files' button in the manuscript submission process.

The maximum file size for additional files is 10 MB, and files will be virus-scanned on submission. If additional files exceed 5 MB, authors are kindly requested to Zip the additional files (without password protection) and send the Zip file containing the additional files as an attachment to e-mail.

Any additional files will be linked into the final published article in the form supplied by the author, but will not be displayed within the paper. They will be made available in exactly the same form as originally provided.

If additional material is provided, please list the following information in a separate section of the manuscript text, immediately following the tables (if any):

  • File name
  • File format (including name and a URL of an appropriate viewer if format is unusual)
  • Title of data
  • Description of data

Additional datafiles should be referenced explicitly by file name within the body of the article, e.g. 'See additional file 1: Movie1 for the original data used to perform this analysis'.

Formats and uploading

Ideally, file formats for additional files should not be platform-specific, and should be viewable using free or widely available tools. The following are examples of suitable formats.

  • Additional documentation
    • PDF (Adobe Acrobat)
  • Animations
    • SWF (Shockwave Flash)
  • Movies
    • MOV (QuickTime)
    • MPG (MPEG)
  • Tabular data
    • XLS (Excel spreadsheet)
    • CSV (Comma separated values)

As with figure files, files should be given the standard file extensions. This is especially important for Macintosh users, since the Mac OS does not enforce the use of standard extensions. Please also make sure that each additional file is a single table, figure or movie (please do not upload linked worksheets or PDF files larger than one sheet).

return to top

Style and language

General

Currently, jHASE can only accept manuscripts written in English. Spelling should be US English or British English, but not a mixture.

Gene names should be in italic, but protein products should be in plain type.

There is no explicit limit on the length of articles submitted, but authors are encouraged to be concise. There is also no restriction on the number of figures, tables or additional files that can be included with each article online. Figure and tables should be sequentially referenced. Authors should include all relevant supporting data with each article.

jHASE will not edit submitted manuscripts for style or language; reviewers may advise rejection of a manuscript if it is compromised by grammatical errors. Authors are advised to write clearly and simply, and to have their article checked by colleagues before submission. In-house copyediting will be minimal. Non-native speakers of English may choose to make use of a copyediting service such as that provided by Biology Editors, Manuscript Presentation Service, International Science Editing and English Manager Science Editing. jHASE has no first-hand experience of these companies and takes no responsibility for the quality of their service.

Help and advice on scientific writing

MedBioWorld also provides a list of resources for science writing. Tim Albert has produced for BioMed Central a list of tips for writing a scientific manuscript. 

Abbreviations

Abbreviations should be used as sparingly as possible. They can be defined when first used or a list of abbreviations can be provided preceding the acknowledgements and references.

Typography
  • Please use double line spacing.
  • Type the text unjustified, without hyphenating words at line breaks.
  • Use hard returns only to end headings and paragraphs, not to rearrange lines.
  • All pages should be numbered and page numbering must be centered and located in the footer of the document.
  • Use the jHASE reference format.
  • Footnotes to text should not be used.
  • Greek and other special characters may be included. If you are unable to reproduce a particular special character, please type out the name of the symbol in full. Please ensure that all special characters used are embedded in the text, otherwise they will be lost during conversion to PDF.

Units

SI Units should be used throughout (litre and molar are permitted, however).

Last revised: 4 April 2009

return to top